Clinical Trials Directory

Trials / Unknown

UnknownNCT01373203

The Role of Fibrocytes in Acute Lung Injury

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Taipei Medical University WanFang Hospital · Academic / Other
Sex
Age
20 Years
Healthy volunteers
Not accepted

Summary

The important character of acute lung injury (ALI) is alveolar capillary membrane damage caused by different diseases, such as sepsis, trauma and shock. One of the important pathological stages is the varying degrees of interstitial fibrosis and semi-permeable alveolar membrane fibrosis. It has been proved that CXCL12/SDF-1 (stromal cell-derived factor-1) induces fibrocyte migration, and promotes fibrosis progression. Study indicated that inhibition of TLR4 receptor signaling pathway improves fibrosis progression induced by ALI, however, the role of fibrocyte in ALI is still unclear. The fibrocytes was significantly increased in asthmatic patients with pulmonary fibrosis, which companies with increased CTGF expression. Therefore, this project assumes that fibrocyte will differentiation to fibroblast/myofibroblast in patient with acute lung injury, which in turn leads to progression of fibrosis. The central hypothesis of this project is that peripheral progenitor cell fibrocytes play an important role in alveolitis caused by acute lung injury. The overall objective of this project is to study the role of fibrocytes in acute lung injury.

Conditions

Timeline

Start date
2011-01-01
Completion
2011-12-01
First posted
2011-06-14
Last updated
2011-06-14

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01373203. Inclusion in this directory is not an endorsement.